EX-23.1 2 t1600767_ex23-1.htm EXHIBIT 23.1
​
Exhibit 23.1​
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements (Nos. 333-205153, 333-183483, and 333-143786) on Form S-8 and (No. 333-187801) on Form S-3 of Cyclacel Pharmaceuticals, Inc. of our report dated March 29, 2016, relating to our audit of the consolidated financial statements, which appear in this Annual Report on Form 10-K of Cyclacel Pharmaceuticals, Inc. for the year ended December 31, 2015. On October 26, 2015, we changed the name of our firm from McGladrey LLP to RSM US LLP.
/s/ RSM US LLP
New York, New York
March 29, 2016